Clinical comparative report of the efficacy in the treatment of non-muscle invasive bladder tumor be-tween front-firing green-light laser enucleation and transurethral plasmakinetic resection
Clinical comparative report of the efficacy in the treatment of non-muscle invasive bladder tumor be-tween front-firing green-light laser enucleation and transurethral plasmakinetic resection
Objective To compare the efficacy in the treatment of non-muscle invasive bladder cancer(NMIBC),between front-firing green-light laser enucleation and transurethral plasmakinetic resection.Methods The clinical data of 80 NMIBC patients treated in the urology department of Anqing Municipal Hospital from March 2019 to March 2020 were retrospectively analyzed.These 80 patients were divided into two groups by random number table method,the experimental group were treated with front-firing green-light laser and 40 patients in the control group were treated with tran-surethral plasma resection of bladder tumor.The intraoperative blood loss,postoperative bladder ir-rigation time,catheter indwelling time,postoperative hospital stay and the occurrence of intraopera-tive and postoperative complications were compared between the two groups.Results The opera-tions were successfully completed in both groups.There was no significant difference in operation time or re-currence rate between the experimental group and the control group(P＞0.05).The amount of intraoperative blood loss,postoperative bladder irrigation time,catheter retention time and postoperative hospital stay in the experimental group were superior to those in the control group.In terms of surgical complications,the inci-dence of postoperative bleeding,obturator nerve reflex and bladder perforation in the experimental group was significantly lower than that in the control group,with statistical significance(P＜0.05).Conclusions Compared with transurethral plasma resection of bladder tumor,the treatment of NMIBC by front-firing green-light laser is safer and more effective.It has the advantages of minimall invasion,less bleeding and low complication risk,so it is worthy of clinical promotion.
维普
万方数据